Yesterday, Sanofi Canada issued a news release announcing that “iconic brand Rolaids is back,” and not a moment too soon because the drug company commissioned an Ipsos survey that showed – quel surprise! – that the January-to-March period is “heartburn season”!
The news release presents the results of the ‘research’ in detail, but fails to remind us when and why Rolaids ever left us. The release did remind us that, as a commercial several years ago claimed, the spelling of ‘relief’ is remarkably similar to the spelling of the brand name, and that not only is Rolaids back, but Sanofi is the new owner of the brand. Continue reading →